Subscribe
  • Home
  • Issues
    • Online First
    • Latest Issue
    • Issue Archive
    • Special Issues
  • Browse By Topic
    • Personalized Medicine
    • Economics & Value
    • FDA Approvals, News & Updates
    • COVID-19
    • Cholangiocarcinoma
    • View All Topics ›
  • Conference Correspondent
    • ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
    • ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
  • Web Exclusives
    • Web Exclusive Articles
    • Videos
    • Interview with the Innovators
    • Prostate Cancer Diagnostics Monthly Minutes
    • Webinars
    • Quick Quiz
    • Press Releases
  • Association for Value-Based Cancer Care
  • VBCM
  • Value-Based Care in Myeloma
  • Articles

Articles

Community Trials Essential to Broad Knowledge
By Ed Pezalla, MD, MPH
Value-Based Care, VBCC Perspectives
September 2010, Vol 1, No 4
Several sessions at the recent ASCO meeting considered new standards for community-based oncology research and the development of comparative effectiveness research (CER) methods.
Read More

Comparative Effectiveness Research in Oncology Is High Priority
ASCO Conference
September 2010, Vol 1, No 4
Read More

Cost-Effectiveness in the New Comparative Effectiveness Landscape
ASCO Conference
September 2010, Vol 1, No 4
Read More

Moving Targets: Personalized Medicine and Targeted Therapies
Personalized Medicine
July/August 2010, Vol 1, No 3
Read More

Medicare, a Major P(l)ayer, Not Ready for New Payment Policy Evidence
July/August 2010, Vol 1, No 3
Read More

Direct-to-Consumer Genetics/Genomics: A “New Paradigm” in Providing Healthcare Information
Genomic Testing
July/August 2010, Vol 1, No 3
Read More

Clinical Trials: Understanding Cost, Coverage Implications
Clinical Trials
July/August 2010, Vol 1, No 3
Read More

How Will Costs Be Contained in the New Healthcare Environment?
Economics & Value
July/August 2010, Vol 1, No 3
Read More

Adherence to Colon Cancer Chemotherapy Guidelines Depends on Treatment Setting
Chemotherapy, Personalized Medicine
July/August 2010, Vol 1, No 3
Read More

Reasons for Breast Cancer Care Disparities Remain Unclear
Disparities in Oncology
July/August 2010, Vol 1, No 3
Read More

Page 323 of 329

  • 320
  • 321
  • 322
  • 323
  • 324
  • 325
  • 326

Top Trending Articles

1.
Immunotherapy Helps Navy Veteran Beat Stage 4 Lung Cancer
2.
HOPA Highlights: What's New in 2025?
3.
AUGTYRO (Repotrectinib) for the Treatment of ROS1-Positive Non-Small Cell Lung Cancer
  • Home
  • Issues
    • Online First
    • Latest Issue
    • Issue Archive
    • Special Issues
  • Browse By Topic
    • Personalized Medicine
    • Economics & Value
    • FDA Approvals, News & Updates
    • COVID-19
    • Cholangiocarcinoma
    • View All Topics ›
  • Conference Correspondent
    • ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
    • ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
  • Web Exclusives
    • Web Exclusive Articles
    • Videos
    • Interview with the Innovators
    • Prostate Cancer Diagnostics Monthly Minutes
    • Webinars
    • Quick Quiz
    • Press Releases
  • Association for Value-Based Cancer Care
  • VBCM
  • Value-Based Care in Myeloma
Subscribe

Stay In The Know

Stay up to date on the matters of value in cancer by signing up for the free, bi-monthly VBCC print publication and VBCC weekly e‑newsletter.

Subscribe
  • About
  • About VBCC
  • Mission Statement
  • Advertising
  • Contact
  • Contribute
  • Submit a Manuscript
  • Editorial / Publishing Policies
  • Author Guidelines
  • Publications
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Cholangiocarcinoma News
Amplity
© Amplity, Inc. All Rights Reserved. Privacy Policy.